5167 POSTER A Multicenter Randomized Phase II Study of KRN125 (Pegfilgrastim) to Determine the Optimal Dosage in Japanese Breast Cancer Patients Receiving TAC Treatment
Authors:
- N. MasudaNMN. Masuda
- S. NakamuraSNS. Nakamura
- Y. ItoYIY. Ito
- Y. TokudaYTY. Tokuda
- K. TamuraKTK. Tamura
- 1 September 2011
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S380